Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...

Currently, diagnosing Parkinson’s disease can be a challenging process ... Imaging technologies such as DaTscan and MRI may also be used to observe brain changes associated with the disease.

Magnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...

AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...

Cleveland Clinic researchers are three years into a longitudinal brain study, in which volunteers are undergoing periodic medical imaging, cognitive assessments and neuropsychological exams to help ...

A woman who is at least the fourth generation of her family to suffer a "cruel" brain disorder, which leaves people trapped ...

The Vattikuti Foundation has donated a state-of-the-art Insightec MR-Guided HIFU system to AIIMS, along with five years of ...

Alum, Faculty of Science > Co-founder and CEO of Foqus Technologies Current magnetic resonance imaging (MRI) machines ...

Discover how MR-guided focused ultrasound offers a revolutionary non-invasive treatment for tremors and epilepsy reducing ...

Neurodiagnostics Market Research Report In 2020, the global neurodiagnostics market was valued at $6,530 million and is projected to reach ...